Literature DB >> 19512922

Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?

Nadeem Sarwar1, Naveed Sattar.   

Abstract

PURPOSE OF REVIEW: Despite over 50 years of research, the relevance of triglycerides to coronary heart disease risk remains uncertain. RECENT
FINDINGS: Contrary to prevailing views, recent studies demonstrate that the long-term within-individual variability of triglyceride measurements is similar to that of other lipid fractions. Several prospective studies have reported on associations of circulating triglyceride levels with coronary heart disease risk, but it remains unclear whether observed associations are dependent on levels of conventional risk factors (especially other lipids) or are importantly modified under different circumstances (especially by fasting status). Ongoing large-scale studies should help clarify such outstanding uncertainties and assess whether measurement of triglyceride levels can better identify individuals at increased risk of coronary heart disease than measurement of conventional risk factors alone. Available interventions that lower levels of triglycerides are unable to judge causality as such interventions typically influence levels of several lipid fractions. Study of genetic variants that regulate triglyceride levels may provide an alternative approach to assess causality.
SUMMARY: Although recent studies have progressed our understanding of triglycerides and coronary heart disease, several outstanding uncertainties remain unresolved. Ongoing studies should help clarify these, including whether measurement of triglyceride levels can help improve coronary heart disease risk assessment, and study of genetic variants may help better understand any causal role.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19512922     DOI: 10.1097/MOL.0b013e32832dd4dc

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  7 in total

1.  Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.

Authors:  Nadeem Sarwar; Manjinder S Sandhu; Sally L Ricketts; Adam S Butterworth; Emanuele Di Angelantonio; S Matthijs Boekholdt; Willem Ouwehand; Hugh Watkins; Nilesh J Samani; Danish Saleheen; Debbie Lawlor; Muredach P Reilly; Aroon D Hingorani; Philippa J Talmud; John Danesh
Journal:  Lancet       Date:  2010-05-08       Impact factor: 79.321

2.  Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic syndrome: a cross-sectional study.

Authors:  Evan Coffman; Jennifer Richmond-Bryant
Journal:  Popul Health Metr       Date:  2015-03-14

3.  Associations between Dietary Patterns, ADRβ2 Gln27Glu and ADRβ3 Trp64Arg with Regard to Serum Triglyceride Levels: J-MICC Study.

Authors:  Hinako Nanri; Yuichiro Nishida; Kazuyo Nakamura; Keitaro Tanaka; Mariko Naito; Guang Yin; Nobuyuki Hamajima; Naoyuki Takashima; Sadao Suzuki; Yora Nindita; Michiko Kohno; Hirokazu Uemura; Teruhide Koyama; Satoyo Hosono; Haruo Mikami; Michiaki Kubo; Hideo Tanaka
Journal:  Nutrients       Date:  2016-09-06       Impact factor: 5.717

Review 4.  The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Authors:  Robert A Hegele; Henry N Ginsberg; M John Chapman; Børge G Nordestgaard; Jan Albert Kuivenhoven; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Olivier S Descamps; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Luis Masana; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Gerald F Watts; Olov Wiklund
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-23       Impact factor: 32.069

5.  Effects of a Plant Sterol or Stanol Enriched Mixed Meal on Postprandial Lipid Metabolism in Healthy Subjects.

Authors:  Sabine Baumgartner; Ronald P Mensink; Jogchum Plat
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

Review 6.  Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.

Authors:  Diego Estrada-Luna; María Araceli Ortiz-Rodriguez; Lizett Medina-Briseño; Elizabeth Carreón-Torres; Jeannett Alejandra Izquierdo-Vega; Ashutosh Sharma; Juan Carlos Cancino-Díaz; Oscar Pérez-Méndez; Helen Belefant-Miller; Gabriel Betanzos-Cabrera
Journal:  Molecules       Date:  2018-10-23       Impact factor: 4.411

7.  Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions.

Authors:  Stephen Burgess; Daniel F Freitag; Hassan Khan; Donal N Gorman; Simon G Thompson
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.